NEULANDLAB.NS
Key Ratios

Net Profit Margin: Making high profit when compared with its revenue which generally means company’s strong hold in the market, and good efficiency of the business

Acid Test Ratio: It has good liquidity, which means it can can cover its liabilities without relying on inventory

Inventory Turnover: Very Slow Inventory movement or over stocking risk

Coverage Analysis: At a very strong financial position where company is easily able to pay its interest payments from its earnings (EBIT + Lease Payments)

Debt to Equity Ratio: Company has low debt when compared to its equity which means it is financially stable

P/E Ratio: Overvalued stock which means company is making very less revenue per share but stock price is very high which represent speculative stock

Performance Graph
Financial Ratios
Ratio Value
PE Ratio59.20
Net Profit Margin0.20
Acid Test Ratio1.33
Inventory Turnover2.09
Coverage Ratio17.76
Debt to Equity0.07
Key Ratios

Net Profit Margin: Making high profit when compared with its revenue which generally means company’s strong hold in the market, and good efficiency of the business

Return on Assets: Very high efficiency of the assets which indicates assets are making high contribution to the revenue

Return on Equity: High income of the company when compared with its equity, which means efficient equity

Performance Graph
Profitability Ratios
Ratio Value
Net Profit Margin0.20
Return on Assets1.65
Return on Equity0.23
Performance Graph
Key Ratios

Acid Test Ratio: It has good liquidity, which means it can can cover its liabilities without relying on inventory

Current Ratio: It would not have any issues to cover its short-term liabilities because of strong liquidity

Performance Graph
Liquidity Ratios
Ratio Value
Acid Test Ratio1.33
Current Ratio2.15
Performance Graph
Key Ratios

Inventory Turnover: Very Slow Inventory movement or over stocking risk

Performance Graph
Efficiency Ratios
Ratio Value
Inventory Turnover2.09
Performance Graph
Key Ratios

Coverage Analysis: At a very strong financial position where company is easily able to pay its interest payments from its earnings (EBIT + Lease Payments)

Performance Graph
Coverage Ratios
Ratio Value
Coverage Ratio17.76
Performance Graph
Key Ratios

Debt to Equity Ratio: Company has low debt when compared to its equity which means it is financially stable

Interest Coverage Ratio: Company is at low risk of getting default as it can easily cover its interest payments and strong financial health

Performance Graph
Solvency Ratios
Ratio Value
Debt to Equity Ratio0.07
Interest Coverage Ratio37.25
Performance Graph
Key Ratios

P/E Ratio: Overvalued stock which means company is making very less revenue per share but stock price is very high which represent speculative stock

Dividend Yield: Low yield, focus on growth rather than dividends (Low dividend yield, which means company is focusing on growth

Performance Graph
Market Ratios
Ratio Value
P/E Ratio59.20
Gross Profit Margin0.52
Price to Book Ratio13.85
Dividend Yield0.00
Performance Graph

Balance Sheet Analysis of Neuland Laboratories Limited

The balance sheet in the financial statement of the company shows its financial position at a particular point in time.

It consists of the following:

  • Assets: Something that the company owns and that gives financial benefits over a period of time.
  • Liabilities: Something that a company owes and that has a financial burden on the company.
  • Equity: It is basically the owner’s share in the company.

The formula is:

Assets = Liabilities + Equity
đź“ŚAssets:
Asset
Value & Year
2024
2023
2022
Total Assets 18325610000 15797645000 13834884000
Total Non Current Assets 9114803000 8188704000 8026959000
Other Non Current Assets 218184000 39669000 13868000
Non Current Prepaid Assets 91038000 98649000 92326000
Non Current Deferred Taxes Assets - - -
Financial Assets - - -
Investment In Financial Assets 12788000 5249000 4974000
Held To Maturity Securities - - -
Available For Sale Securities 12788000 5249000 4813000
Financial Assets Fair Value - 161000 161000
Long Term Equity Investment - - -
Investments In Associates At Cost - - -
Goodwill And Other Intangible Assets 2819191000 2807617000 2815812000
Other Intangible Assets 24581000 13007000 21202000
Goodwill 2794610000 2794610000 2794610000
Net Ppe 5897941000 4998252000 4865762000
Accumulated Depreciation -2567676000 -2048669000 -1595201000
Gross Ppe 8465617000 7046921000 6460963000
Construction In Progress 670730000 423930000 204571000
Other Properties 5227211000 4574322000 89968000
Machinery Furniture Equipment 5336414000 4634835000 4337258000
Buildings And Improvements 2170990000 1880728000 1811706000
Land And Improvements 287483000 107428000 107428000
Properties - - -
Current Assets 9210807000 7608941000 5807925000
Other Current Assets 1168000 537597000 552068000
Hedging Assets Current - - 5865000
Assets Held For Sale Current - - -
Restricted Cash 142100000 136883000 152681000
Prepaid Assets 707111000 506900000 497799000
Inventory 3504219000 2792334000 2652101000
Other Inventories - - -
Finished Goods 890305000 636951000 526674000
Work In Process 1476974000 1178888000 1194095000
Raw Materials 1136940000 976495000 931332000
Other Receivables 95093000 100985000 71533000
Taxes Receivable - - -
Accounts Receivable 3735262000 3617680000 2343264000
Allowance For Doubtful Accounts Receivable -6315000 -35257000 -42056000
Gross Accounts Receivable 3741577000 3652937000 2385320000
Cash Cash Equivalents And Short Term Investments 1025854000 454159000 84682000
Other Short Term Investments 150100000 207171000 33768000
Cash And Cash Equivalents 875754000 454159000 50914000
Cash Equivalents 770600000 250100000 -
Cash Financial 105154000 204059000 50914000
đź“Ś Liabilities & Equity
Liability/Equity
Value & Year
2024
2023
2022
Net Debt - 760940000 2258547000
Total Debt 953896000 1284497000 2405320000
Total Liabilities Net Minority Interest 5498562000 5856680000 5429876000
Total Non Current Liabilities Net Minority Interest 1221730000 1467110000 1798310000
Other Non Current Liabilities - 278000 298000
Derivative Product Liabilities - - -
Non Current Pension And Other Postretirement Benefit Plans 76098000 102909000 119143000
Trade And Other Payables Non Current - - -
Non Current Deferred Revenue - - -
Non Current Deferred Taxes Liabilities 604392000 582989000 566994000
Long Term Debt And Capital Lease Obligation 541240000 780934000 1111875000
Long Term Capital Lease Obligation 92034000 38475000 69396000
Long Term Debt 449206000 742459000 1042479000
Long Term Provisions 76098000 102909000 119143000
Current Liabilities 4276832000 4389570000 3631566000
Other Current Liabilities 49639000 35587000 36231000
Current Deferred Taxes Liabilities - - -
Current Debt And Capital Lease Obligation 412656000 503563000 1293445000
Current Capital Lease Obligation 36792000 30923000 26463000
Current Debt 375864000 472640000 1266982000
Pension And Other Post Retirement Benefit Plans Current 466196000 175397000 95637000
Current Provisions 16359000 15266000 668446000
Payables 1994094000 1896426000 1258017000
Other Payable 72311000 81194000 82987000
Dividends Payable 1378000 1162000 1198000
Total Tax Payable 814000 104019000 -
Accounts Payable 1919591000 1710051000 1173832000
Common Stock Equity 12827048000 9940965000 8405008000
Total Capitalization 13276254000 10683424000 9447487000
Total Equity Gross Minority Interest 12827048000 9940965000 8405008000
Minority Interest - - -
Stockholders Equity 12827048000 9940965000 8405008000
Other Equity Interest 12698043000 9811960000 8276003000
Treasury Stock - - -
Retained Earnings 7524837000 4652347000 3081316000
Additional Paid In Capital 4977735000 4977735000 4977735000
Capital Stock 129005000 129005000 129005000
Common Stock 129005000 129005000 129005000

Income statement interpretation for Neuland Laboratories Limited

The income statement in the financial statement of the company shows its company financial performance over a period in time.

It consists of the following:

  • Revenue: It is the total amount of money earned from the core business activity of the company.
  • Expenses: It is the total amount required for running the full functionality of the company.
  • Profit or loss:In very simple terms, when a company pays its expenses using its revenue, then what’s left is profit, and in case expenses are more when compared with revenue, then it is loss.
đź“ŚRevenue & Profitability
Revenue/Profitability
Value & Year
2024
2023
2022
Total Revenue 15156631000 11608985000 9233341000
Operating Revenue 15156631000 11608985000 9233341000
Cost Of Revenue 7337967000 6137853000 5535020000
Gross Profit 7818664000 5471132000 3698321000
Ebitda 4722108000 2789253000 1407362000
Ebit 4125109000 2261479000 916960000
Operating Income 4073822000 2343414000 960903000
Net Income 3000789000 1635176000 638220000
Net Income From Continuing Operation Net Minority Interest 3000789000 1635176000 638220000
Net Income From Continuing And Discontinued Operation 3000789000 1635176000 638220000
Net Income Common Stockholders 3000789000 1635176000 638220000
Net Income Including Noncontrolling Interests 3000789000 1635176000 638220000
Net Income Discontinuous Operations - - -
Net Income Continuous Operations 3000789000 1635176000 638220000
Normalized Income 3001685268 1614498542 652264918
Normalized Ebitda 4723307000 2761971000 1425443000
Total Unusual Items -1199000 27282000 -18081000
Total Unusual Items Excluding Goodwill -1199000 27282000 -18081000
đź“ŚExpenses & Taxes
Expenses/Taxes
Value & Year
2024
2023
2022
Reconciled Depreciation 596999000 527774000 490402000
Reconciled Cost Of Revenue 7337967000 6137853000 5535020000
Total Expenses 11082809000 9265571000 8272438000
Operating Expense 3744842000 3127718000 2737418000
Other Operating Expenses 324668000 271293000 261193000
Depreciation And Amortization In Income Statement 596999000 527774000 490402000
Amortization 10558000 12556000 14809000
Depreciation Income Statement 586441000 515218000 475593000
Selling General And Administration 648530000 594707000 430945000
Selling And Marketing Expense 339358000 295793000 274019000
General And Administrative Expense 309172000 298914000 156926000
Rent And Landing Fees 9202000 8381000 7132000
Tax Provision 1013576000 522288000 183405000
Pretax Income 4014365000 2157464000 821625000
Other Non Operating Income Expenses 125443000 5204000 4826000
Special Income Charges -1199000 27282000 -18081000
Other Special Charges 1199000 -27282000 18081000
Write Off - - -
Net Non Operating Interest Income Expense -57706000 -115108000 -124994000
Total Other Finance Cost 29230000 26656000 39609000
Interest Expense Non Operating 110744000 104015000 95335000
Interest Income Non Operating 82268000 15563000 9950000
đź“Ś Earnings Per Share
Earnings Per Share
Value & Year
2024
2023
2022
Diluted Eps 233.89 127.45 49.74
Basic Eps 233.89 127.45 49.74
Diluted Ni Avail To Com Stockholders 3000789000 1635176000 638220000
Net Income From Continuing Operations 4014365000 2157464000 821625000
Minority Interests - - -

Cash flow analysis for Neuland Laboratories Limited

The cashflow statement in the financial statement of the company shows how cash is moving in or moving out of the company over a period of time.

It consists of the following:

  • Operating activities: Cash flow from the core business operations.
  • Investing activities: Cashflow from investments made by the company.
  • Financing activities: These are cash from loans or by issuing shares or paying out dividends.
đź“ŚOperating Cash Flow
Operating Cash Flow
Value & Year
2024
2023
2022
Operating Cash Flow 2611767000 2372119000 603888000
Changes In Cash 422081000 399176000 25940000
Taxes Refund Paid -1116035000 -436280000 -204928000
Change In Working Capital -907318000 -128342000 -675849000
Change In Other Current Liabilities -100656000 879608000 -101160000
Change In Other Current Assets -191483000 -49287000 169507000
Change In Payable 203284000 543595000 -397171000
Change In Inventory -711885000 -140233000 -176024000
Change In Receivables -86629000 -1343279000 -171001000
Other Non Cash Items 57706000 115108000 125001000
Stock Based Compensation - - -
Provision And Write Off Of Assets -2495000 46698000 5679000
Depreciation And Amortization 596999000 527774000 490402000
Amortization Cash Flow 10558000 12556000 14809000
Depreciation 586441000 515218000 475593000
đź“ŚInvesting Cash Flow
Investing Cash Flow
Value & Year
2024
2023
2022
Investing Cash Flow -1496868000 -614985000 -955163000
Net Other Investing Changes - - -
Interest Received Cfi 78932000 15389000 10878000
Dividends Received Cfi - - -
Net Investment Purchase And Sale -151734000 15998000 16606000
Sale Of Investment 3367000 15998000 16606000
Purchase Of Investment -155101000 - -
Net Business Purchase And Sale - - -
Sale Of Business - - -
Purchase Of Business - - -
Net Ppe Purchase And Sale -1424066000 -646372000 -972499000
Sale Of Ppe 12632000 14913000 4361000
Purchase Of Ppe -1436698000 -661285000 -976860000
Net Intangibles Purchase And Sale - - -
Purchase Of Intangibles - - -
đź“Ś Financing Cash Flow
Financing Cash Flow
Value & Year
2024
2023
2022
Financing Cash Flow -692818000 -1357958000 377215000
Net Other Financing Charges - - -
Interest Paid Cff -140549000 -131532000 -135590000
Cash Dividends Paid -128299000 -64149000 -38490000
Common Stock Dividend Paid -128299000 -64149000 -38490000
Net Common Stock Issuance - - -
Common Stock Payments - - -
Common Stock Issuance - - -
Repurchase Of Capital Stock - - -
Repayment Of Debt -482621000 -1166809000 -222607000
Issuance Of Debt 88219000 30994000 451268000
Issuance Of Capital Stock - - -
Net Issuance Payments Of Debt -394402000 -1135815000 576615000
Net Short Term Debt Issuance -111575000 -810572000 347954000
Short Term Debt Issuance - - 347954000
Net Long Term Debt Issuance -282827000 -325243000 228661000
Long Term Debt Payments -371046000 -356237000 -222607000
Long Term Debt Issuance 88219000 30994000 451268000
Net Preferred Stock Issuance - - -
Preferred Stock Payments - - -

Summary

Fundamental Overview of NEULANDLAB.NS (Neuland Laboratories Limited)

Above is the summary for fundamental analysis of Neuland Laboratories Limited , whose ticker name is NEULANDLAB.NS and belongs to sector Healthcare, and it is listed in NSE (National Stock Exchange).

The Neuland Laboratories Limited which is listed in NSE (National Stock Exchange) has a PE ratio of 59.20, NEULANDLAB.NS has a net profit margin of 0.20, the acid test ratio for NEULANDLAB.NS is 1.33, NEULANDLAB.NS has an inventory turnover of 2.09, and NEULANDLAB.NS has debt-to-equity ratio of 0.07.

The NEULANDLAB.NS whose company name is Neuland Laboratories Limited has made profit/loss of 7818664000 with total revenue of 15156631000, NEULANDLAB.NS has assets worth of 18325610000.

1. What is fundamental analysis?

Fundamental analysis is looking into a company’s real business performance by analyzing financial statements, earning reports, and key valuation ratios.

Basically, fundamental analysis involves examining a company’s revenue, profits, losses, debts, assets, liabilities, and ratios calculated using these values to determine long-term investment strategies.

Fundamental analysis may not work for short-term trading of stock; it is usually incorporated by long-term investors.

2. Importance of Fundamental Analysis

Imagine you are locking a good amount of funds into an unknown company for many years. Sounds stupid, right?

This is where fundamental analysis comes into the picture, which turns an unknown enemy into a known friend.

As fundamental analysis involves calculating how a company is actually performing, the real revenue, profits, assets, liabilities, debts, and more. This helps investors to determine what the actual current financial condition of the company is, how much the company’s stock price is justified when compared to earnings (Corporate earnings reports India) that it is making through business, what the probability is that the company will go bankrupt in the future, how much growth the company has shown in the past, and other financial ratios.

All these calculations and analyses determine the financial health of the company, historical business growth, company’s efficiency, and its stock price compared with real earnings (Corporate earnings reports India), which helps traders to make investment decisions for long-term investment strategies.

2. How to Use Our Tool

  • Search for the stock that you want to analyze in the search bar by typing the name of the company or ticker.
  • Once you land on the Stock Analytics Page, click on “Fundamental Analysis”; this will take you to the fundamental analysis page.
  • Apply Filter
  • On the “Fundamental Analysis” page, the first tab is for “Summary and Ratio,” where in the top section you can find the overall summary of the stock’s fundamental analysis, where on the leftmost side it has a textual summary, then in the middle a gauge chart that represents overall financial health, and then a list of important ratios.
  • Apply Filter
  • Then in the same “Summary and Ratio” tab, we have included a detailed analysis of stock in various aspects, which includes “Profitability Analysis,” “Liquidity Analysis,” “Efficiency Analysis,” “Coverage Analysis,” Solvency Analysis,” and “Market Analysis,” which divide the stock’s fundamentals into the above aspects and analyze each in the same format as for overall analysis, where the leftmost side has a textual summary, then in the middle a gauge chart that represents overall analysis of the particular section, and then a list of important ratios. Required for the particular analysis.
  • Apply Filter